Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Ian Forrest et al.|The Lancet Respiratory Medicine|2022Cited by 211
Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal TransitionBin Shan, Joseph A. Lasky|Journal of Biological Chemistry|2008Cited by 171
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathwayShigeki Saito, Joseph A. Lasky|PLoS ONE|2017Cited by 115
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary FibrosisIván O. Rosas, Augustine M.K. Choi, Hilary J. Goldberg et al.|CHEST Journal|2017Cited by 97
HDAC8 inhibition ameliorates pulmonary fibrosisShigeki Saito, Joseph A. Lasky|American Journal of Physiology-Lung Cellular and Molecular Physiology|2018Cited by 67